MiR-27b-5p promotes gastric cancer progression by targeting CREBZF to regulate the STAT3 pathway

doi:10.4251/wjgo.v18.i3.113781

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 3

This Article

(27)

(29)

(0)

(8)

(486)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Oncol. Mar 15, 2026; 18(3): 113781
Published online Mar 15, 2026. doi: 10.4251/wjgo.v18.i3.113781

Table 2 Association between plasma miR-27b-5p levels and clinicopathological features in 168 gastric cancer patients

Characteristics	n	MiR-27b-5p expression	Mann-Whitney U	P value
Gender
Male	108	0.1183	3071	0.5763
Female	60	0.1162	3071	0.5763
Age
≥ 60	48	0.1134	2603	0.3315
< 60	120	0.1177	2603	0.3315
T
T1	71	0.0934	1871	P < 0.0001
T2 + T3 + T4	97	0.2031	1871	P < 0.0001
N
N0	113	0.1088	2347	0.0098
N1 + N2 + N3	55	0.1984	2347	0.0098
M
M0	137	0.1132	1569	0.0228
M1	31	0.2404	1569	0.0228
Clinical stages
I	107	0.1063	2208	0.0004
II + III + IV	61	0.2243	2208	0.0004

Full Size Table

Citation: Ma FC, Zhang GL, Chen GQ, Ling JW, Li YF, Chi BT, Tang YL, Peng W, Chen G, Wei DM, Rong MH, Ge LY. MiR-27b-5p promotes gastric cancer progression by targeting CREBZF to regulate the STAT3 pathway. World J Gastrointest Oncol 2026; 18(3): 113781
URL: https://www.wjgnet.com/1948-5204/full/v18/i3/113781.htm
DOI: https://dx.doi.org/10.4251/wjgo.v18.i3.113781

Ma FC, Zhang GL, Chen GQ, Ling JW, Li YF, Chi BT, Tang YL, Peng W, Chen G, Wei DM, Rong MH, Ge LY. MiR-27b-5p promotes gastric cancer progression by targeting CREBZF to regulate the STAT3 pathway. World J Gastrointest Oncol 2026; 18(3): 113781 [DOI: 10.4251/wjgo.v18.i3.113781]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.